SECdecoded Read filings, not jargon.

HENRY SCHEIN, INC. FY 2025 10-K, explained in plain English

HSIC · 10-K for the period ending December 27, 2025, filed February 24, 2026 · Read the original on SEC.gov →

Key financials — as reported

Total revenue$13.2B
Gross margin31.1%
Operating income$653.0M
Net income$398.0M
Diluted EPS$3.27
Cash & equivalents— not reported
Total assets$11.2B
Long-term debt$2.3B

Key takeaway

Henry Schein operates as a global health care distributor and specialty products/technology provider, serving over one million dental and medical customers across 34 countries.

🔒 4 more takeaways in the full analysis

Beneath the surface

The filing discloses $16 million in intangible asset impairment and $103 million in contingent consideration liability changes tied to acquisitions, both of which can weigh on reported operating income without being called out in headline figures.

🔒 4 more insights a headline reader would miss

This is the free preview. The full analysis explains every line item above and includes 8 more findings — plus insider trades, activist stakes, and 8-K events for HSIC.

Read the full analysis free Free account · 5 full analyses included · no card required